Campbell & CO Investment Adviser LLC - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 158 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2018$172,000
+47.0%
21,410
+36.4%
0.13%
+34.7%
Q1 2018$117,000–15,702–0.10%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2018.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders